
At LogiPharma USA 2026, Mark Talens explains how end-to-end visibility lets pharma see its value chain across functions, and where supply chain monitoring is headed next.
Johnson & Johnson VP comments on building digital capabilities into workflows.
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Wayne Rothman, VP, Value Chain Management, Johnson & Johnson, dessribes the process of building digital capabilities into workflows.






